Effects of radioiodination on hormone binding ability

Area of Science:

• Endocrinology
• Radiochemistry
• Biochemistry

Background:

• Human chorionic gonadotropin (hCG) is a crucial hormone in pregnancy.
• Radiolabeling is often used to study hormone-receptor interactions.
• The stability of radiolabeled hormones can impact experimental results.

Purpose of the Study:

• To investigate the impact of 125I labeling on the binding ability of hCG.
• To compare the half-life of radiolabeled hCG determined by different methods.
• To assess the influence of labeled hormone degradation on binding parameters.

Main Methods:

• 125I labeling of human chorionic gonadotropin.
• Binding experiments conducted at various time points post-labeling.
• Scatchard analysis using rat testes as the receptor source.
• Comparison of specific radioactivity half-life from self-displacement analysis versus theoretical isotope half-life.

Main Results:

• A significant difference was observed in the specific radioactivity half-life of 125I-labeled hCG.
• The hormone's half-life decreased to 3.10 days, contrasting with the 125I isotope's 60-day half-life.
• Scatchard analysis yielded constant affinity constant (Ka) and binding site numbers when using self-displacement radioactivity, but significant variations when using the theoretical half-life.
• Labeled hormone degradation was identified as a key factor affecting binding ability.

Conclusions:

• The degradation of 125I-labeled hCG significantly impacts its binding ability.
• Accurate determination of radiolabeled hormone half-life is critical for reliable binding studies.
• Self-displacement analysis provides a more accurate assessment of specific radioactivity in binding experiments involving hCG.